Molecular diagnosis of DMD/BMD

Area of Science:

• Genetics
• Molecular Biology
• Neurology

Background:

• Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are X-linked recessive disorders.
• DMD presents a severe, fatal course, while BMD has a milder clinical profile.
• Accurate diagnosis is essential for patient counseling and management.

Purpose of the Study:

• To review the evolution of molecular diagnostic criteria for DMD/BMD.
• To highlight the importance of accurate diagnosis in managing these genetic disorders.
• To explore emerging molecular diagnostic techniques.

Main Methods:

• Review of established molecular diagnostic techniques including multiplex PCR, southern blot, DGGE, western blot, immunocytochemistry, CA repeat analysis, capillary electrophoresis, heteroduplex analysis, SSCE, and direct sequencing.
• Discussion of the potential of RNA fingerprinting as a novel diagnostic tool.

Main Results:

• A range of molecular diagnostic methods have been developed for DMD/BMD.
• Current methods offer various approaches to identify genetic defects.
• RNA fingerprinting represents a promising area for future diagnostic development.

Conclusions:

• The accurate molecular diagnosis of DMD and BMD is critical for effective patient care.
• Continuous advancements in molecular biology have expanded diagnostic capabilities.
• RNA fingerprinting holds significant potential to advance the molecular diagnostics of muscular dystrophies.